UBS O'Connor’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History
Bought
Maintained
Sold
Other funds holding DTRT
MC
OCAM
PAMP
BFM
CAC
LP
SC
PC
UBS O'Connor's DTRT Position: Q4 2022 in Review
UBS O'Connor sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q4 2022, closing a stake of 243,293 shares — an estimated $2.47M sold.
UBS O'Connor first reported a position in DTRT in Q4 2021 and held it in 3 quarters. The position peaked at $2.69M in Q2 2022. 17 funds tracked by Wall St. Rank hold DTRT as of Q4 2022.
- UBS O'Connor reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
- UBS O'Connor sold 243,293 DTRT Health Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $2.47M.
- UBS O'Connor first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 3 quarters.
- UBS O'Connor's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $2.69M in Q2 2022.
- 17 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q4 2022.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.